ADENOVIRUS - ANVISA Registration 80254180245
Access comprehensive regulatory information for ADENOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80254180245 and manufactured by OXOID (ELY) LIMITED.. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including R-BIOPHARM AG, NOVATEC IMMUNDIAGNOSTICA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80254180245
25351151397201706
04930429000139
Company Information
Dates and Status
Apr 24, 2017
VIGENTE
09/18/2025 19:00:01
ADENOVÍRUS
Família Adenovirus Antigen Fluorescence Rapid Test Cassette (Swab)
ZHEJIANG ORIENT GENE BIOTECH CO., LTD.
82444370260
Sep 01, 2025
ADENOVÍRUS
Adenovírus ELISA IgG
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
10338930334
Aug 18, 2025
ADENOVÍRUS
RIDASCREEN® Adenovirus
R-BIOPHARM AG
82890930001
Jan 27, 2025
ADENOVÍRUS
VIASURE Adenovirus Real Time PCR Detection Kit
CERTEST BIOTEC, S.L.
82149920103
Jan 27, 2025
ADENOVÍRUS
Família Adenovirus Run Control
EXACT DIAGNOSTICS
80020690436
Dec 23, 2024

